Report Detail

Request for Sample of this report

Pharma & Healthcare Global Intravenous (IV) Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM2806708
    • |
  • 02 August, 2024
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Intravenous (IV) Ibuprofen market size was valued at USD 7250.7 million in 2023 and is forecast to a readjusted size of USD 14880 million by 2030 with a CAGR of 10.8% during review period.
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
The Global Info Research report includes an overview of the development of the Intravenous (IV) Ibuprofen industry chain, the market status of Pain (100 mg Dose, 200 mg Dose), Fever (100 mg Dose, 200 mg Dose), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravenous (IV) Ibuprofen.
Regionally, the report analyzes the Intravenous (IV) Ibuprofen markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravenous (IV) Ibuprofen market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravenous (IV) Ibuprofen market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravenous (IV) Ibuprofen industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., 100 mg Dose, 200 mg Dose).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravenous (IV) Ibuprofen market.
Regional Analysis: The report involves examining the Intravenous (IV) Ibuprofen market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravenous (IV) Ibuprofen market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravenous (IV) Ibuprofen:
Company Analysis: Report covers individual Intravenous (IV) Ibuprofen manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravenous (IV) Ibuprofen This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pain, Fever).
Technology Analysis: Report covers specific technologies relevant to Intravenous (IV) Ibuprofen. It assesses the current state, advancements, and potential future developments in Intravenous (IV) Ibuprofen areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravenous (IV) Ibuprofen market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravenous (IV) Ibuprofen market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
Market segment by Application
Pain
Fever
Inflammation
Major players covered
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous (IV) Ibuprofen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous (IV) Ibuprofen, with price, sales, revenue and global market share of Intravenous (IV) Ibuprofen from 2019 to 2024.
Chapter 3, the Intravenous (IV) Ibuprofen competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous (IV) Ibuprofen breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intravenous (IV) Ibuprofen market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous (IV) Ibuprofen.
Chapter 14 and 15, to describe Intravenous (IV) Ibuprofen sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Intravenous (IV) Ibuprofen
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Intravenous (IV) Ibuprofen Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 100 mg Dose
    • 1.3.3 200 mg Dose
    • 1.3.4 400 mg Dose
    • 1.3.5 800 mg Dose
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Intravenous (IV) Ibuprofen Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pain
    • 1.4.3 Fever
    • 1.4.4 Inflammation
  • 1.5 Global Intravenous (IV) Ibuprofen Market Size & Forecast
    • 1.5.1 Global Intravenous (IV) Ibuprofen Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Intravenous (IV) Ibuprofen Sales Quantity (2019-2030)
    • 1.5.3 Global Intravenous (IV) Ibuprofen Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Cumberland Pharmaceuticals
    • 2.1.1 Cumberland Pharmaceuticals Details
    • 2.1.2 Cumberland Pharmaceuticals Major Business
    • 2.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
    • 2.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Cumberland Pharmaceuticals Recent Developments/Updates
  • 2.2 Alveda Pharmaceuticals
    • 2.2.1 Alveda Pharmaceuticals Details
    • 2.2.2 Alveda Pharmaceuticals Major Business
    • 2.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
    • 2.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Alveda Pharmaceuticals Recent Developments/Updates
  • 2.3 CSL Limited
    • 2.3.1 CSL Limited Details
    • 2.3.2 CSL Limited Major Business
    • 2.3.3 CSL Limited Intravenous (IV) Ibuprofen Product and Services
    • 2.3.4 CSL Limited Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CSL Limited Recent Developments/Updates
  • 2.4 Sandor Medicaids
    • 2.4.1 Sandor Medicaids Details
    • 2.4.2 Sandor Medicaids Major Business
    • 2.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Product and Services
    • 2.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Sandor Medicaids Recent Developments/Updates
  • 2.5 PT. Soho Industri Pharmasi
    • 2.5.1 PT. Soho Industri Pharmasi Details
    • 2.5.2 PT. Soho Industri Pharmasi Major Business
    • 2.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product and Services
    • 2.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 PT. Soho Industri Pharmasi Recent Developments/Updates
  • 2.6 Germin MED
    • 2.6.1 Germin MED Details
    • 2.6.2 Germin MED Major Business
    • 2.6.3 Germin MED Intravenous (IV) Ibuprofen Product and Services
    • 2.6.4 Germin MED Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Germin MED Recent Developments/Updates
  • 2.7 Grifols
    • 2.7.1 Grifols Details
    • 2.7.2 Grifols Major Business
    • 2.7.3 Grifols Intravenous (IV) Ibuprofen Product and Services
    • 2.7.4 Grifols Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Grifols Recent Developments/Updates
  • 2.8 Gloria Pharmaceuticals
    • 2.8.1 Gloria Pharmaceuticals Details
    • 2.8.2 Gloria Pharmaceuticals Major Business
    • 2.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
    • 2.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Gloria Pharmaceuticals Recent Developments/Updates
  • 2.9 Al Nabeel International
    • 2.9.1 Al Nabeel International Details
    • 2.9.2 Al Nabeel International Major Business
    • 2.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Product and Services
    • 2.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Al Nabeel International Recent Developments/Updates
  • 2.10 Laboratorios Valmorca
    • 2.10.1 Laboratorios Valmorca Details
    • 2.10.2 Laboratorios Valmorca Major Business
    • 2.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product and Services
    • 2.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Laboratorios Valmorca Recent Developments/Updates

3 Competitive Environment: Intravenous (IV) Ibuprofen by Manufacturer

  • 3.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Intravenous (IV) Ibuprofen Revenue by Manufacturer (2019-2024)
  • 3.3 Global Intravenous (IV) Ibuprofen Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Intravenous (IV) Ibuprofen by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Intravenous (IV) Ibuprofen Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Intravenous (IV) Ibuprofen Manufacturer Market Share in 2023
  • 3.5 Intravenous (IV) Ibuprofen Market: Overall Company Footprint Analysis
    • 3.5.1 Intravenous (IV) Ibuprofen Market: Region Footprint
    • 3.5.2 Intravenous (IV) Ibuprofen Market: Company Product Type Footprint
    • 3.5.3 Intravenous (IV) Ibuprofen Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Intravenous (IV) Ibuprofen Market Size by Region
    • 4.1.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Intravenous (IV) Ibuprofen Consumption Value by Region (2019-2030)
    • 4.1.3 Global Intravenous (IV) Ibuprofen Average Price by Region (2019-2030)
  • 4.2 North America Intravenous (IV) Ibuprofen Consumption Value (2019-2030)
  • 4.3 Europe Intravenous (IV) Ibuprofen Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value (2019-2030)
  • 4.5 South America Intravenous (IV) Ibuprofen Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Intravenous (IV) Ibuprofen Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Type (2019-2030)
  • 5.2 Global Intravenous (IV) Ibuprofen Consumption Value by Type (2019-2030)
  • 5.3 Global Intravenous (IV) Ibuprofen Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Application (2019-2030)
  • 6.2 Global Intravenous (IV) Ibuprofen Consumption Value by Application (2019-2030)
  • 6.3 Global Intravenous (IV) Ibuprofen Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Intravenous (IV) Ibuprofen Sales Quantity by Type (2019-2030)
  • 7.2 North America Intravenous (IV) Ibuprofen Sales Quantity by Application (2019-2030)
  • 7.3 North America Intravenous (IV) Ibuprofen Market Size by Country
    • 7.3.1 North America Intravenous (IV) Ibuprofen Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Intravenous (IV) Ibuprofen Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Intravenous (IV) Ibuprofen Sales Quantity by Type (2019-2030)
  • 8.2 Europe Intravenous (IV) Ibuprofen Sales Quantity by Application (2019-2030)
  • 8.3 Europe Intravenous (IV) Ibuprofen Market Size by Country
    • 8.3.1 Europe Intravenous (IV) Ibuprofen Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Intravenous (IV) Ibuprofen Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Intravenous (IV) Ibuprofen Market Size by Region
    • 9.3.1 Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Intravenous (IV) Ibuprofen Sales Quantity by Type (2019-2030)
  • 10.2 South America Intravenous (IV) Ibuprofen Sales Quantity by Application (2019-2030)
  • 10.3 South America Intravenous (IV) Ibuprofen Market Size by Country
    • 10.3.1 South America Intravenous (IV) Ibuprofen Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Intravenous (IV) Ibuprofen Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Intravenous (IV) Ibuprofen Market Size by Country
    • 11.3.1 Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Intravenous (IV) Ibuprofen Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Intravenous (IV) Ibuprofen Market Drivers
  • 12.2 Intravenous (IV) Ibuprofen Market Restraints
  • 12.3 Intravenous (IV) Ibuprofen Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Intravenous (IV) Ibuprofen and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Intravenous (IV) Ibuprofen
  • 13.3 Intravenous (IV) Ibuprofen Production Process
  • 13.4 Intravenous (IV) Ibuprofen Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Intravenous (IV) Ibuprofen Typical Distributors
  • 14.3 Intravenous (IV) Ibuprofen Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Intravenous (IV) Ibuprofen . Industry analysis & Market Report on Intravenous (IV) Ibuprofen is a syndicated market report, published as Global Intravenous (IV) Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Intravenous (IV) Ibuprofen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo